Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Fibrosis and cirrhosis prediction in Hep C without liver biopsies

The combination of all tests without liver biopsy correctly classifies most patients, shows October's Journal of Viral Hepatitis.

News image

fiogf49gjkf04

Noninvasive indexes have been developed to predict fibrosis staging.

Dr Philippe Halfron and colleagues from France assessed the diagnostic accuracy of these indexes in comparison with liver histology in Hepatitis C virus-infected patients.

A total of 235 consecutive patients with Hepatitis C infection from the Fibropaca multicenter independent study were included.

The research team assessed FibroTest, aspartate aminotransferase to platelet ratio index and Forns score in the cohort and compared with liver histology performed on the same day.

Combining all tests without liver biopsy allowed 81% patients to be correctly classified
Journal of Viral Hepatitis

The main end point was the area under characteristic curves for the diagnosis of significant fibrosis and cirrhosis.

The team noted that the patient's mean age was 46 years, 55% were males, 42% had significant fibrosis and 7% had cirrhosis.

For the diagnosis of fibrosis, respective area under characteristic curves of FibroTest, aspartate aminotransferase to platelet ratio index and Forns score were 0.8, 0.7 and 0.8

For cirrhosis prognosis, the team found that area under characteristic curves of FibroTest and aspartate aminotransferase to platelet ratio index were both 0.8.

Using each index independently, all patients were classified by FbroTest.

The researchers observed that 91% patients were classified by aspartate aminotransferase to platelet ratio index and 55% by Forns score.

There were significantly more cases of discordances between aspartate aminotransferase to platelet ratio index and liver biopsy than between FibroTest or Forns score and liver biopsy.

Performing all scores without liver biopsy allowed fibrosis to be well evaluated in 81% of patients, including patients with FibroTest failure.

The team found that liver biopsy remained mandatory to evaluate fibrosis in 19% of patients.

Dr Halfron's team concludes, “Our study shows that performing all the tests and liver biopsy improves the diagnostic accuracy for liver fibrosis in chronic Hepatitis C patients without patent comorbidities.”

“The combination of all tests with liver biopsy allowed 96% patients to be correctly classified.”

“The combination of all tests without liver biopsy allowed 81% patients to be correctly classified, and liver biopsy remained mandatory in some patients.”

J Vir Hep 2006: 13(10): 659
22 September 2006

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us